| Michael Fanaras, RPH | |
|
1 Granite Pl, Concord, NH 03301-3271 | |
| (603) 226-8686 | |
| (603) 225-6579 |
| Full Name | Michael Fanaras |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1 Granite Pl, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154952430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHCY-00880 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Fanaras, RPH 1 Granite Pl, Concord, NH 03301-3271 Ph: (603) 226-8686 | Michael Fanaras, RPH 1 Granite Pl, Concord, NH 03301-3271 Ph: (603) 226-8686 |
News Archive
As the incidence of liver cancer continues to grow - fueled in large part, by rising rates of hepatitis C infections - so too does the need for tests to help diagnose the disease at an earlier stage.
Using fewer-;but higher-;doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
An unprecedented alliance of leading scientists, health professionals, and children's and environmental health advocates agree for the first time that today's scientific evidence supports a link between exposures to toxic chemicals in air, water, food and everyday products and children's risks for neurodevelopmental disorders.
State sponsors of the nationwide effort to block a government requirement to purchase health insurance today sent a letter to President Obama decrying their exclusion from tomorrow's bipartisan health reform summit.
› Verified 9 days ago
Mr. Richard Jon Tripp, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-225-2711 | |
Mr. John Michael Tracy Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Locke Rd, Suite 3, Concord, NH 03301 Phone: 603-223-0380 Fax: 603-223-0347 | |
Mary Kate Langlais-mcnutt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 92 South St, Concord, NH 03301 Phone: 603-228-8400 | |
Mr. John Christopher Wakelin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Main St, Concord, NH 03301 Phone: 603-224-9591 Fax: 603-224-5361 | |
Joseph Pirani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Granite Pl Ste N200, Concord, NH 03301 Phone: 603-226-8686 | |
Mrs. Ann Marie Bisson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Main St, Concord, NH 03301 Phone: 603-224-9591 | |
Mr. Khiem D Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Hall St, Concord, NH 03103 Phone: 603-623-3532 |